Naseem Amin - May 17, 2024 Form 4 Insider Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Role
Director
Signature
/s/ Jerad G. Seurer, as Attorney-in-Fact
Stock symbol
AVDL
Transactions as of
May 17, 2024
Transactions value $
$0
Form type
4
Date filed
5/21/2024, 05:29 PM
Previous filing
Jun 9, 2023
Next filing
Aug 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVDL Stock Option (Right to Buy) Award $0 +49.5K $0.00 49.5K May 17, 2024 Ordinary Shares 49.5K $15.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options become exercisable in three equal annual installments on each of the first three anniversaries following the 5/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date.